Skip to content
Disclosery

EXANE DERIVATIVES: DNN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DNN, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,442,058 DNN shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,442,058 shares
    Change vs previous 13F +327,129 shares

    0.81% of the 13F portfolio, value $1,416,642.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,114,929 shares
    Change vs previous 13F -281,780 shares

    0.51% of the 13F portfolio, value $1,816,804.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,396,709 shares
    Change vs previous 13F +1,076,143 shares

    0.47% of the 13F portfolio, value $1,912,281.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 320,566 shares
    Change vs previous 13F 0 shares

    0.12% of the 13F portfolio, value $463,005.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 320,566 shares
    Change vs previous 13F -236,455 shares

    0.08% of the 13F portfolio, value $349,329.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 557,021 shares
    Change vs previous 13F -88,203 shares

    0.18% of the 13F portfolio, value $605,272.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 645,224 shares
    Change vs previous 13F +81,000 shares

    0.13% of the 13F portfolio, value $425,415.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 564,224 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $235,978.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).